This site is intended for healthcare professionals only
Share this article

Testing for kidney disease in type 2 diabetes: consensus statement and recommendations

Diabetic kidney disease (DKD) is an important consideration for healthcare professionals supporting people with type 2 diabetes in primary care. An annual clinical review provides a critical opportunity for DKD screening and monitoring, using estimated glomerular filtration rate (eGFR) and urine albumin:creatinine ratio (UACR) to gain an understanding of an individual’s level of adverse risk. This article aims to improve understanding of DKD and its impact, as well as the importance of screening for early identification. Key aspects of national and international clinical guidelines are explained, and useful resources are signposted. A quick-reference DKD Screening/Monitoring Tool has also been provided within the supplementary material to guide and support appropriate and timely DKD testing for all individuals with type 2 diabetes.

Click here to access the article.

Related content
Prevention of diabetic maculopathy: Trial of oral medication begins
Free for all UK & Ireland healthcare professionals

Sign up to all DiabetesontheNet journals


By clicking ‘Subscribe’, you are agreeing that are able to email you periodic newsletters. You may unsubscribe from these at any time. Your info is safe with us and we will never sell or trade your details. For information please review our Privacy Policy.

Are you a healthcare professional? This website is for healthcare professionals only. To continue, please confirm that you are a healthcare professional below.

We use cookies responsibly to ensure that we give you the best experience on our website. If you continue without changing your browser settings, we’ll assume that you are happy to receive all cookies on this website. Read about how we use cookies.